Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.
<h4>Context</h4>Adrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine neoplasm, with limited therapeutic options. Activating β-catenin somatic mutations are found in ACC and have been associated with a poor clinical outcome. In fact, activation of the Wnt/β-catenin sig...
Guardado en:
Autores principales: | Sébastien Gaujoux, Constanze Hantel, Pierre Launay, Stéphane Bonnet, Karine Perlemoine, Lucile Lefèvre, Marine Guillaud-Bataille, Felix Beuschlein, Frédérique Tissier, Jérôme Bertherat, Marthe Rizk-Rabin, Bruno Ragazzon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e8baa0d2cca04cffbfe551e33e213bea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma.
por: Marine Guillaud-Bataille, et al.
Publicado: (2014) -
Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas
por: Isabel Weigand, et al.
Publicado: (2017) -
β-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesis
por: Sining Leng, et al.
Publicado: (2020) -
Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression
por: Giulia Cantini, et al.
Publicado: (2021) -
Acta Nº295
por: Banco Central de Chile
Publicado: (2019)